[
  {
    "ts": "2026-01-16T05:10:47+00:00",
    "headline": "Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion?",
    "summary": "Earlier this week, Labcorp Holdings Inc. declared a quarterly cash dividend of US$0.72 per share, payable on March 12, 2026 to shareholders of record as of February 27, 2026. In parallel, Labcorp expanded its Plasma Detect molecular residual disease portfolio with highly sensitive ctDNA tests for breast, lung and colon cancers, reinforcing its role in precision oncology diagnostics and personalized post-treatment monitoring. We’ll now examine how Labcorp’s expanded MRD testing portfolio...",
    "url": "https://finance.yahoo.com/news/labcorp-lh-quietly-reframing-oncology-051047065.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a3f7b54f-d0d6-3db6-86af-d9864886958b",
      "content": {
        "id": "a3f7b54f-d0d6-3db6-86af-d9864886958b",
        "contentType": "STORY",
        "title": "Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion?",
        "description": "",
        "summary": "Earlier this week, Labcorp Holdings Inc. declared a quarterly cash dividend of US$0.72 per share, payable on March 12, 2026 to shareholders of record as of February 27, 2026. In parallel, Labcorp expanded its Plasma Detect molecular residual disease portfolio with highly sensitive ctDNA tests for breast, lung and colon cancers, reinforcing its role in precision oncology diagnostics and personalized post-treatment monitoring. We’ll now examine how Labcorp’s expanded MRD testing portfolio...",
        "pubDate": "2026-01-16T05:10:47Z",
        "displayTime": "2026-01-16T05:10:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pUPV1p_Bw8ydOCyP5dgMaw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SLvgYYeIn3Dw6STv9CZZCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/labcorp-lh-quietly-reframing-oncology-051047065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/labcorp-lh-quietly-reframing-oncology-051047065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]